Global Biological Drugs Market Research Report 2023

Report ID: 1994756 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Biological Drugs Market Overview
    1.1 Product Overview and Scope of Biological Drugs
    1.2 Biological Drugs Segment by Type
        1.2.1 Global Biological Drugs Market Value Comparison by Type (2023-2029)
        1.2.2 Therapeutic Protein
        1.2.3 Monoclonal Antibody
        1.2.4 Vaccine
        1.2.5 Others
    1.3 Biological Drugs Segment by Application
        1.3.1 Global Biological Drugs Market Value by Application: (2023-2029)
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Others
    1.4 Global Biological Drugs Market Size Estimates and Forecasts
        1.4.1 Global Biological Drugs Revenue 2018-2029
        1.4.2 Global Biological Drugs Sales 2018-2029
        1.4.3 Global Biological Drugs Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Biological Drugs Market Competition by Manufacturers
    2.1 Global Biological Drugs Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Biological Drugs Average Price by Manufacturers (2018-2023)
    2.4 Global Biological Drugs Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Biological Drugs, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Biological Drugs, Product Type & Application
    2.7 Biological Drugs Market Competitive Situation and Trends
        2.7.1 Biological Drugs Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Biological Drugs Players Market Share by Revenue
        2.7.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Drugs Retrospective Market Scenario by Region
    3.1 Global Biological Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Biological Drugs Global Biological Drugs Sales by Region: 2018-2029
        3.2.1 Global Biological Drugs Sales by Region: 2018-2023
        3.2.2 Global Biological Drugs Sales by Region: 2024-2029
    3.3 Global Biological Drugs Global Biological Drugs Revenue by Region: 2018-2029
        3.3.1 Global Biological Drugs Revenue by Region: 2018-2023
        3.3.2 Global Biological Drugs Revenue by Region: 2024-2029
    3.4 North America Biological Drugs Market Facts & Figures by Country
        3.4.1 North America Biological Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Biological Drugs Sales by Country (2018-2029)
        3.4.3 North America Biological Drugs Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Biological Drugs Market Facts & Figures by Country
        3.5.1 Europe Biological Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Biological Drugs Sales by Country (2018-2029)
        3.5.3 Europe Biological Drugs Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Biological Drugs Market Facts & Figures by Country
        3.6.1 Asia Pacific Biological Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Biological Drugs Sales by Country (2018-2029)
        3.6.3 Asia Pacific Biological Drugs Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Biological Drugs Market Facts & Figures by Country
        3.7.1 Latin America Biological Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Biological Drugs Sales by Country (2018-2029)
        3.7.3 Latin America Biological Drugs Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Biological Drugs Market Facts & Figures by Country
        3.8.1 Middle East and Africa Biological Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Biological Drugs Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Biological Drugs Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E
4 Segment by Type
    4.1 Global Biological Drugs Sales by Type (2018-2029)
        4.1.1 Global Biological Drugs Sales by Type (2018-2023)
        4.1.2 Global Biological Drugs Sales by Type (2024-2029)
        4.1.3 Global Biological Drugs Sales Market Share by Type (2018-2029)
    4.2 Global Biological Drugs Revenue by Type (2018-2029)
        4.2.1 Global Biological Drugs Revenue by Type (2018-2023)
        4.2.2 Global Biological Drugs Revenue by Type (2024-2029)
        4.2.3 Global Biological Drugs Revenue Market Share by Type (2018-2029)
    4.3 Global Biological Drugs Price by Type (2018-2029)
5 Segment by Application
    5.1 Global Biological Drugs Sales by Application (2018-2029)
        5.1.1 Global Biological Drugs Sales by Application (2018-2023)
        5.1.2 Global Biological Drugs Sales by Application (2024-2029)
        5.1.3 Global Biological Drugs Sales Market Share by Application (2018-2029)
    5.2 Global Biological Drugs Revenue by Application (2018-2029)
        5.2.1 Global Biological Drugs Revenue by Application (2018-2023)
        5.2.2 Global Biological Drugs Revenue by Application (2024-2029)
        5.2.3 Global Biological Drugs Revenue Market Share by Application (2018-2029)
    5.3 Global Biological Drugs Price by Application (2018-2029)
6 Key Companies Profiled
    6.1 Bristol-Myers Squibb
        6.1.1 Bristol-Myers Squibb Corporation Information
        6.1.2 Bristol-Myers Squibb Description and Business Overview
        6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio
        6.1.5 Bristol-Myers Squibb Recent Developments/Updates
    6.2 Eli Lilly
        6.2.1 Eli Lilly Corporation Information
        6.2.2 Eli Lilly Description and Business Overview
        6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Eli Lilly Biological Drugs Product Portfolio
        6.2.5 Eli Lilly Recent Developments/Updates
    6.3 Takeda
        6.3.1 Takeda Corporation Information
        6.3.2 Takeda Description and Business Overview
        6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Takeda Biological Drugs Product Portfolio
        6.3.5 Takeda Recent Developments/Updates
    6.4 Pfizer
        6.4.1 Pfizer Corporation Information
        6.4.2 Pfizer Description and Business Overview
        6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Pfizer Biological Drugs Product Portfolio
        6.4.5 Pfizer Recent Developments/Updates
    6.5 Amgen
        6.5.1 Amgen Corporation Information
        6.5.2 Amgen Description and Business Overview
        6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Amgen Biological Drugs Product Portfolio
        6.5.5 Amgen Recent Developments/Updates
    6.6 F. Hoffmann-La Roche
        6.6.1 F. Hoffmann-La Roche Corporation Information
        6.6.2 F. Hoffmann-La Roche Description and Business Overview
        6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio
        6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
    6.7 Johnson & Johnson
        6.6.1 Johnson & Johnson Corporation Information
        6.6.2 Johnson & Johnson Description and Business Overview
        6.6.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Johnson & Johnson Biological Drugs Product Portfolio
        6.7.5 Johnson & Johnson Recent Developments/Updates
    6.8 Merck
        6.8.1 Merck Corporation Information
        6.8.2 Merck Description and Business Overview
        6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Merck Biological Drugs Product Portfolio
        6.8.5 Merck Recent Developments/Updates
    6.9 Abbott Laboratories
        6.9.1 Abbott Laboratories Corporation Information
        6.9.2 Abbott Laboratories Description and Business Overview
        6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Abbott Laboratories Biological Drugs Product Portfolio
        6.9.5 Abbott Laboratories Recent Developments/Updates
    6.10 Baxter
        6.10.1 Baxter Corporation Information
        6.10.2 Baxter Description and Business Overview
        6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Baxter Biological Drugs Product Portfolio
        6.10.5 Baxter Recent Developments/Updates
    6.11 Novartis
        6.11.1 Novartis Corporation Information
        6.11.2 Novartis Biological Drugs Description and Business Overview
        6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Novartis Biological Drugs Product Portfolio
        6.11.5 Novartis Recent Developments/Updates
    6.12 Biogen
        6.12.1 Biogen Corporation Information
        6.12.2 Biogen Biological Drugs Description and Business Overview
        6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Biogen Biological Drugs Product Portfolio
        6.12.5 Biogen Recent Developments/Updates
    6.13 GlaxoSmithKline
        6.13.1 GlaxoSmithKline Corporation Information
        6.13.2 GlaxoSmithKline Biological Drugs Description and Business Overview
        6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio
        6.13.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Biological Drugs Industry Chain Analysis
    7.2 Biological Drugs Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Biological Drugs Production Mode & Process
    7.4 Biological Drugs Sales and Marketing
        7.4.1 Biological Drugs Sales Channels
        7.4.2 Biological Drugs Distributors
    7.5 Biological Drugs Customers
8 Biological Drugs Market Dynamics
    8.1 Biological Drugs Industry Trends
    8.2 Biological Drugs Market Drivers
    8.3 Biological Drugs Market Challenges
    8.4 Biological Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer
List of Tables
    Table 1. Global Biological Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Biological Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Biological Drugs Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Biological Drugs Sales (Units) of Key Manufacturers (2018-2023)
    Table 5. Global Biological Drugs Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Biological Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Biological Drugs Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Biological Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Biological Drugs, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Biological Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Biological Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Biological Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drugs as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Biological Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Biological Drugs Sales by Region (2018-2023) & (Units)
    Table 18. Global Biological Drugs Sales Market Share by Region (2018-2023)
    Table 19. Global Biological Drugs Sales by Region (2024-2029) & (Units)
    Table 20. Global Biological Drugs Sales Market Share by Region (2024-2029)
    Table 21. Global Biological Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Biological Drugs Revenue Market Share by Region (2018-2023)
    Table 23. Global Biological Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Biological Drugs Revenue Market Share by Region (2024-2029)
    Table 25. North America Biological Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Biological Drugs Sales by Country (2018-2023) & (Units)
    Table 27. North America Biological Drugs Sales by Country (2024-2029) & (Units)
    Table 28. North America Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Biological Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Biological Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Biological Drugs Sales by Country (2018-2023) & (Units)
    Table 32. Europe Biological Drugs Sales by Country (2024-2029) & (Units)
    Table 33. Europe Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Biological Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Biological Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Biological Drugs Sales by Region (2018-2023) & (Units)
    Table 37. Asia Pacific Biological Drugs Sales by Region (2024-2029) & (Units)
    Table 38. Asia Pacific Biological Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Biological Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Biological Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Biological Drugs Sales by Country (2018-2023) & (Units)
    Table 42. Latin America Biological Drugs Sales by Country (2024-2029) & (Units)
    Table 43. Latin America Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Biological Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Biological Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Biological Drugs Sales by Country (2018-2023) & (Units)
    Table 47. Middle East & Africa Biological Drugs Sales by Country (2024-2029) & (Units)
    Table 48. Middle East & Africa Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Biological Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Biological Drugs Sales (Units) by Type (2018-2023)
    Table 51. Global Biological Drugs Sales (Units) by Type (2024-2029)
    Table 52. Global Biological Drugs Sales Market Share by Type (2018-2023)
    Table 53. Global Biological Drugs Sales Market Share by Type (2024-2029)
    Table 54. Global Biological Drugs Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Biological Drugs Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Biological Drugs Revenue Market Share by Type (2018-2023)
    Table 57. Global Biological Drugs Revenue Market Share by Type (2024-2029)
    Table 58. Global Biological Drugs Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Biological Drugs Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Biological Drugs Sales (Units) by Application (2018-2023)
    Table 61. Global Biological Drugs Sales (Units) by Application (2024-2029)
    Table 62. Global Biological Drugs Sales Market Share by Application (2018-2023)
    Table 63. Global Biological Drugs Sales Market Share by Application (2024-2029)
    Table 64. Global Biological Drugs Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Biological Drugs Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Biological Drugs Revenue Market Share by Application (2018-2023)
    Table 67. Global Biological Drugs Revenue Market Share by Application (2024-2029)
    Table 68. Global Biological Drugs Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Biological Drugs Price (USD/Unit) by Application (2024-2029)
    Table 70. Bristol-Myers Squibb Corporation Information
    Table 71. Bristol-Myers Squibb Description and Business Overview
    Table 72. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Bristol-Myers Squibb Biological Drugs Product
    Table 74. Bristol-Myers Squibb Recent Developments/Updates
    Table 75. Eli Lilly Corporation Information
    Table 76. Eli Lilly Description and Business Overview
    Table 77. Eli Lilly Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Eli Lilly Biological Drugs Product
    Table 79. Eli Lilly Recent Developments/Updates
    Table 80. Takeda Corporation Information
    Table 81. Takeda Description and Business Overview
    Table 82. Takeda Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Takeda Biological Drugs Product
    Table 84. Takeda Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Pfizer Biological Drugs Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Amgen Corporation Information
    Table 91. Amgen Description and Business Overview
    Table 92. Amgen Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Amgen Biological Drugs Product
    Table 94. Amgen Recent Developments/Updates
    Table 95. F. Hoffmann-La Roche Corporation Information
    Table 96. F. Hoffmann-La Roche Description and Business Overview
    Table 97. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. F. Hoffmann-La Roche Biological Drugs Product
    Table 99. F. Hoffmann-La Roche Recent Developments/Updates
    Table 100. Johnson & Johnson Corporation Information
    Table 101. Johnson & Johnson Description and Business Overview
    Table 102. Johnson & Johnson Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Johnson & Johnson Biological Drugs Product
    Table 104. Johnson & Johnson Recent Developments/Updates
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Business Overview
    Table 107. Merck Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Merck Biological Drugs Product
    Table 109. Merck Recent Developments/Updates
    Table 110. Abbott Laboratories Corporation Information
    Table 111. Abbott Laboratories Description and Business Overview
    Table 112. Abbott Laboratories Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Abbott Laboratories Biological Drugs Product
    Table 114. Abbott Laboratories Recent Developments/Updates
    Table 115. Baxter Corporation Information
    Table 116. Baxter Description and Business Overview
    Table 117. Baxter Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Baxter Biological Drugs Product
    Table 119. Baxter Recent Developments/Updates
    Table 120. Novartis Corporation Information
    Table 121. Novartis Description and Business Overview
    Table 122. Novartis Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Novartis Biological Drugs Product
    Table 124. Novartis Recent Developments/Updates
    Table 125. Biogen Corporation Information
    Table 126. Biogen Description and Business Overview
    Table 127. Biogen Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Biogen Biological Drugs Product
    Table 129. Biogen Recent Developments/Updates
    Table 130. GlaxoSmithKline Corporation Information
    Table 131. GlaxoSmithKline Description and Business Overview
    Table 132. GlaxoSmithKline Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. GlaxoSmithKline Biological Drugs Product
    Table 134. GlaxoSmithKline Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Biological Drugs Distributors List
    Table 138. Biological Drugs Customers List
    Table 139. Biological Drugs Market Trends
    Table 140. Biological Drugs Market Drivers
    Table 141. Biological Drugs Market Challenges
    Table 142. Biological Drugs Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Biological Drugs
    Figure 2. Global Biological Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Biological Drugs Market Share by Type in 2022 & 2029
    Figure 4. Therapeutic Protein Product Picture
    Figure 5. Monoclonal Antibody Product Picture
    Figure 6. Vaccine Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Biological Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Biological Drugs Market Share by Application in 2022 & 2029
    Figure 10. Hospitals
    Figure 11. Ambulatory Surgical Centers
    Figure 12. Others
    Figure 13. Global Biological Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Biological Drugs Market Size (2018-2029) & (US$ Million)
    Figure 15. Global Biological Drugs Sales (2018-2029) & (Units)
    Figure 16. Global Biological Drugs Average Price (USD/Unit) & (2018-2029)
    Figure 17. Biological Drugs Report Years Considered
    Figure 18. Biological Drugs Sales Share by Manufacturers in 2022
    Figure 19. Global Biological Drugs Revenue Share by Manufacturers in 2022
    Figure 20. The Global 5 and 10 Largest Biological Drugs Players: Market Share by Revenue in 2022
    Figure 21. Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 22. Global Biological Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 23. North America Biological Drugs Sales Market Share by Country (2018-2029)
    Figure 24. North America Biological Drugs Revenue Market Share by Country (2018-2029)
    Figure 25. U.S. Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Canada Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Europe Biological Drugs Sales Market Share by Country (2018-2029)
    Figure 28. Europe Biological Drugs Revenue Market Share by Country (2018-2029)
    Figure 29. Germany Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. France Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. U.K. Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Italy Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Russia Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Asia Pacific Biological Drugs Sales Market Share by Region (2018-2029)
    Figure 35. Asia Pacific Biological Drugs Revenue Market Share by Region (2018-2029)
    Figure 36. China Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Japan Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. South Korea Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. India Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Australia Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Taiwan Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Indonesia Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Thailand Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Malaysia Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Philippines Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Latin America Biological Drugs Sales Market Share by Country (2018-2029)
    Figure 47. Latin America Biological Drugs Revenue Market Share by Country (2018-2029)
    Figure 48. Mexico Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Argentina Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Biological Drugs Sales Market Share by Country (2018-2029)
    Figure 52. Middle East & Africa Biological Drugs Revenue Market Share by Country (2018-2029)
    Figure 53. Turkey Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. U.A.E Biological Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Global Sales Market Share of Biological Drugs by Type (2018-2029)
    Figure 57. Global Revenue Market Share of Biological Drugs by Type (2018-2029)
    Figure 58. Global Biological Drugs Price (USD/Unit) by Type (2018-2029)
    Figure 59. Global Sales Market Share of Biological Drugs by Application (2018-2029)
    Figure 60. Global Revenue Market Share of Biological Drugs by Application (2018-2029)
    Figure 61. Global Biological Drugs Price (USD/Unit) by Application (2018-2029)
    Figure 62. Biological Drugs Value Chain
    Figure 63. Biological Drugs Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Frequently Asked Questions
Biological Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biological Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biological Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gypsum Wallboard

This report aims to provide a comprehensive presentation of the global market for Gypsum Wallboar ... Read More